Dr. Alagpulinsa is a Research Fellow in Medicine at the Massachusetts General
Hospital Vaccine and Immunotherapy Center and Harvard Medical School. Dr.
Alagpulinsa is a trained pharmacist, pharmacologist and interdisciplinary
biomedical scientist.
Dr. Chen joined VIC in 2015 with a focus on mesenchymal stem/stromal cells
(MSCs) and MSC-derived intracellular vesicles/exosomes for therapy of various
cancers. He is actively involved in the preclinical development of vaccines and
immunotherapies for cancer by regrouping and redirecting immune responses
in the tumor microenvironment to combat cancer.
Dr. Dai is an Associate Member of VIC. His current research is focused on
developing light-based technologies for preventing and treating infectious
diseases. Particularly, he is considered a world leader who is responsible for
launching the new research area of antimicrobial blue light therapy for
multidrug-resistant infections.
Dr. Ruxandra Sîrbulescu is a Principal Investigator in the Vaccine and
Immunotherapy Center, Instructor in Investigation at Massachusetts General
Hospital, and Instructor of Medicine at Harvard Medical School. Dr. Sîrbulescu is
a trained neurobiologist whose research interests focus on regenerative
medicine.